Andrew D Redfern (Andrew Redfern)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Bone Mineral Density

Top Venues

Cancer medicine

Prostate cancer and prostatic diseases

Clinical & experimental metastasis

This page only lists publications with an associated author ORCID identifier.

Publications

Hilary Laura Martin, Andrew D Redfern
Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence. Cancer medicine (2024)
Hilary Laura Martin, Andrew D Redfern
Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence. Cancer medicine (2024)
Hilary Laura Martin, Andrew D Redfern
Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence. Cancer medicine (2024)
Hilary Laura Martin, Andrew D Redfern
Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence. Cancer medicine 13 (1) (2024)
Lap Hing Chi, Andrew D Redfern, Terry Chin Choy Lim Kam Sian, Ian P Street, Allan D Burrows, Suraya Roslan, Roger J Daly, Robin L Anderson
BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis. International journal of molecular sciences 25 (17) (2024)
Charlene Waryah, Eric Alves, Roberta Mazzieri, Riccardo Dolcetti, Erik W Thompson, Andrew D Redfern, Pilar Blancafort
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers 15 (12) (2023)
Mohammed Al-Zubaidi, Pravin Viswambaram, Steve McCombie, Elizabeth Liow, Nat Lenzo, Tom Ferguson, Andrew D Redfern, Richard Gauci, Dickon Hayne
89 Zirconium-labelled girentuximab ( 89 Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma. BMJ open 12 (4) (2022)
Jin-Soo Kim, Dennis R Taaffe, Daniel A Galvão, Timothy D Clay, Andrew D Redfern, Nicolas H Hart, Elin S Gray, Charles J Ryan, Stacey A Kenfield, Fred Saad, Robert U Newton
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer. Prostate cancer and prostatic diseases (2022)
Jessica A Kretzmann, Cameron W Evans, Colette Moses, Anabel Sorolla, Amy L Kretzmann, Edina Wang, Diwei Ho, Mark J Hackett, Benjamin F Dessauvagie, Nicole M Smith, Andrew D Redfern, Charlene Waryah, Marck Norret, Killugudi Swaminathan Iyer, Pilar Blancafort
Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers. Chemical science 10 (33) (2019)
Andrew D Redfern, Lisa J Spalding, Erik W Thompson
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome. Clinical & experimental metastasis 35 (4) (2018)